Abstract
In this supplement to JADPRO, we review the collaborative practice model in the treatment and management of patients with HER2-positive breast cancer. To highlight how collaborative practice works in the real world, we have included comments and discussion with three individuals bringing different perspectives on the breast cancer experience: Angela DeMichele, MD, MSCE, Jennie Greco Lattimer, MSN, BSN, CRNP, and Rachel F., their patient.
